Loading page…
Healthcare
Medpace Holdings, Inc. records an AlphaScore of 68/100 in the Healthcare sector according to the October 11, 2026 snapshot. Key figures include a phenomenal return on equity (ROE) of 98.27% and a gross margin of 72.35%. A primary strength is its exceptional ROE, highlighting elite efficiency in capital allocation. On the risk side, valuation remains high with a price-to-earnings ratio of 35.94 and a forward PE of 31.69.
Written 11/10/2026, 00:32:04 UTC · Snapshot 11/10/2026